
Approval spans early and levodopa-treated disease; a 6-week titration and CYP3A interactions put pharmacists at the center of starting therapy.
In this video, Kenneth Mack, MD, PhD, describes the symptoms, diagnosis, and treatment options for chronic daily headaches in children.
Watch as Kenneth Mack, MD, PhD, a pediatric neurologist at the Mayo Clinic, describes the symptoms, diagnosis, and treatment options for chronic daily headaches in children.






